Mochida Y, Kimura K, Kosuge M, Yoshida K, Iwasawa Y, Hongo Y, Sugiyama M, Ishikawa T, Kuji N, Tochikubo O, Ishii M
Critical Care and Emergency Center, Yokohama City University School of Medicine.
J Cardiol. 1998 May;31(5):255-62.
Rapid and complete reperfusion is important for the reduction of infarct size and mortality in acute myocardial infarction. The optimum reperfusion therapy with regard to the recanalization rate and the time elapsing between onset and complete reperfusion was evaluated. One hundred fifty-four patients with total occlusion of the infarct-related artery within 6 hours of the onset were classified into four therapy groups: PTCA group (n = 58) undergoing primary percutaneous transluminal coronary angioplasty (PTCA), t-PA-IC group (n = 44) receiving tissue plasminogen activator (t-PA) intracoronary infusion, t-PA-IV group (n = 14) receiving intravenous t-PA infusion, and mt-PA-IV group (n = 38) receiving intravenous mutant t-PA infusion. Although the recanalization rate was high in the PTCA group, there were no differences between the four groups as a supplement to immediate or rescue PTCA. The time elapsing between initiation of thrombolysis and complete reperfusion was shorter in the mt-PA-IV group than in the t-PA-IV group. Assuming the time from hospital arrival to initiation of intravenous thrombolysis was 20 min, the recanalization rate at 60 min after arrival in hospital was higher in the mt-PA-IV group than the PTCA and t-PA-IC groups. Although additional coronary angiography and PTCA may be required to improve the low recanalization rate compared with primary PTCA, intravenous infusion of mutant t-PA was the most promising therapy to achieve early reperfusion.
快速和完全再灌注对于降低急性心肌梗死的梗死面积和死亡率很重要。评估了关于再通率以及发病至完全再灌注之间所经过时间的最佳再灌注治疗方法。154例在发病6小时内梗死相关动脉完全闭塞的患者被分为四个治疗组:接受直接经皮冠状动脉腔内血管成形术(PTCA)的PTCA组(n = 58)、接受冠状动脉内输注组织型纤溶酶原激活剂(t-PA)的t-PA-IC组(n = 44)、接受静脉输注t-PA的t-PA-IV组(n = 14)以及接受静脉输注突变型t-PA的mt-PA-IV组(n = 38)。尽管PTCA组的再通率较高,但作为直接或补救性PTCA的补充,四组之间并无差异。mt-PA-IV组从溶栓开始至完全再灌注所经过的时间比t-PA-IV组短。假设从入院到开始静脉溶栓的时间为20分钟,mt-PA-IV组入院后60分钟时的再通率高于PTCA组和t-PA-IC组。尽管与直接PTCA相比,可能需要额外进行冠状动脉造影和PTCA以提高较低的再通率,但静脉输注突变型t-PA是实现早期再灌注最有前景的治疗方法。